• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Precision medicine in the adjuvant treatment of gastric cancer.

作者信息

Gambardella Valentina, Cervantes Andrés

机构信息

Centro de Investigación Biomédica en Red de Cáncer, Department of Medical Oncology, Biomedical Research Institute INCLIVA, University of Valencia, Valencia 46010, Spain.

Centro de Investigación Biomédica en Red de Cáncer, Department of Medical Oncology, Biomedical Research Institute INCLIVA, University of Valencia, Valencia 46010, Spain.

出版信息

Lancet Oncol. 2018 May;19(5):583-584. doi: 10.1016/S1470-2045(18)30131-1. Epub 2018 Mar 19.

DOI:10.1016/S1470-2045(18)30131-1
PMID:29567072
Abstract
摘要

相似文献

1
Precision medicine in the adjuvant treatment of gastric cancer.精准医学在胃癌辅助治疗中的应用
Lancet Oncol. 2018 May;19(5):583-584. doi: 10.1016/S1470-2045(18)30131-1. Epub 2018 Mar 19.
2
Adjuvant chemotherapy for elderly patients (aged 70 or older) with gastric cancer after a gastrectomy with D2 dissection: A single center experience in Korea.D2 根治性胃切除术后老年（70 岁及以上）胃癌患者的辅助化疗：韩国单中心经验
Asia Pac J Clin Oncol. 2015 Dec;11(4):282-7. doi: 10.1111/ajco.12349. Epub 2015 Apr 9.
3
[Second malignancy after gastrectomy for early gastric cancer-is there any evidence that adjuvant chemotherapy for early gastric cancer causes a second malignancy ?].早期胃癌胃切除术后的第二原发性恶性肿瘤——是否有证据表明早期胃癌的辅助化疗会引发第二原发性恶性肿瘤？
Gan To Kagaku Ryoho. 2008 Aug;35(8):1341-5.
4
Evolution of Gastric Cancer Treatment: From the Golden Age of Surgery to an Era of Precision Medicine.胃癌治疗的演变：从外科手术的黄金时代到精准医学时代。
Yonsei Med J. 2015 Sep;56(5):1177-85. doi: 10.3349/ymj.2015.56.5.1177.
5
[From standard to precision treatment: the development of surgery for gastric cancer].[从标准治疗到精准治疗：胃癌手术的发展]
Zhonghua Wai Ke Za Zhi. 2016 Mar 1;54(3):164-8. doi: 10.3760/cma.j.issn.0529-5815.2016.03.002.
6
Palliative gastrectomy in patients with stage IV gastric cancer--our recent experience.IV期胃癌患者的姑息性胃切除术——我们的近期经验
Chirurgia (Bucur). 2010 Jul-Aug;105(4):473-6.
7
Chemoresponse after non-curative gastrectomy for M1 gastric cancer.M1期胃癌非根治性胃切除术后的化疗反应
World J Surg Oncol. 2015 Jan 30;13:13. doi: 10.1186/s12957-015-0447-3.
8
Progress of Gastric Cancer Surgery in the era of Precision Medicine.精准医学时代的胃癌手术进展。
Int J Biol Sci. 2021 Mar 2;17(4):1041-1049. doi: 10.7150/ijbs.56735. eCollection 2021.
9
[Recognition of specialization of minimally invasive treatment for gastric cancer in the era of precision medicine].[精准医学时代胃癌微创治疗的专业化认知]
Zhonghua Wei Chang Wai Ke Za Zhi. 2017 Aug 25;20(8):847-851.
10
Prognostic analysis of submucosa-invasive gastric cancer with lymph node metastasis.伴有淋巴结转移的黏膜下浸润性胃癌的预后分析
Surgery. 2015 Apr;157(4):716-22. doi: 10.1016/j.surg.2014.10.009. Epub 2014 Nov 3.

引用本文的文献

1
An oral microbiota-based deep neural network model for risk stratification and prognosis prediction in gastric cancer.一种基于口腔微生物群的深度神经网络模型用于胃癌风险分层和预后预测。
J Oral Microbiol. 2025 Jan 17;17(1):2451921. doi: 10.1080/20002297.2025.2451921. eCollection 2025.
2
Intratumoral T cells are associated with prognosis and chemotherapy benefit in gastric cancer.肿瘤内T细胞与胃癌的预后及化疗获益相关。
Histol Histopathol. 2025 Jun;40(6):881-889. doi: 10.14670/HH-18-824. Epub 2024 Sep 30.
3
Multitask machine learning-based tumor-associated collagen signatures predict peritoneal recurrence and disease-free survival in gastric cancer.
基于多任务机器学习的肿瘤相关胶原特征可预测胃癌腹膜复发和无病生存。
Gastric Cancer. 2024 Nov;27(6):1242-1257. doi: 10.1007/s10120-024-01551-0. Epub 2024 Sep 14.
4
Resident to exhausted CD4 T cell ratio is associated with the prognosis of gastric cancer.驻留细胞与耗竭性CD4 T细胞的比例与胃癌的预后相关。
Genes Dis. 2023 Sep 7;11(4):101076. doi: 10.1016/j.gendis.2023.101076. eCollection 2024 Jul.
5
Robustly federated learning model for identifying high-risk patients with postoperative gastric cancer recurrence.用于识别胃癌术后复发高危患者的稳健联邦学习模型。
Nat Commun. 2024 Jan 25;15(1):742. doi: 10.1038/s41467-024-44946-4.
6
Development and validation of a nomogram for patients with stage II/III gastric adenocarcinoma after radical surgery.II/III期胃腺癌根治术后患者列线图的开发与验证
Front Surg. 2022 Oct 31;9:956256. doi: 10.3389/fsurg.2022.956256. eCollection 2022.
7
Prognostic and predictive value of a pathomics signature in gastric cancer.胃癌中病理组学特征的预后和预测价值。
Nat Commun. 2022 Nov 12;13(1):6903. doi: 10.1038/s41467-022-34703-w.
8
A Prognostic Nomogram and Heat Map to Predict Survival in Stage II/III Gastric Cancer Patients After Curative Gastrectomy Followed by Adjuvant Chemotherapy.预测II/III期胃癌患者根治性胃切除术后辅助化疗生存率的预后列线图和热图
Cancer Manag Res. 2022 Jan 25;14:287-301. doi: 10.2147/CMAR.S348890. eCollection 2022.
9
Association of Tumor-Associated Collagen Signature With Prognosis and Adjuvant Chemotherapy Benefits in Patients With Gastric Cancer.肿瘤相关胶原特征与胃癌患者预后和辅助化疗获益的关联。
JAMA Netw Open. 2021 Nov 1;4(11):e2136388. doi: 10.1001/jamanetworkopen.2021.36388.
10
Clinicopathologic significance of TROP2 and phospho-TROP2 in gastric cancer.TROP2和磷酸化TROP2在胃癌中的临床病理意义
Mol Clin Oncol. 2021 May;14(5):105. doi: 10.3892/mco.2021.2267. Epub 2021 Mar 19.